logo
Backbencher laments absence of affordable homes in Sibu

Backbencher laments absence of affordable homes in Sibu

DAP's Oscar Ling said many from among the lower- and middle-income bracket in Sibu are waiting for affordable homes. (Bernama pic)
KUALA LUMPUR : A backbencher has urged the government to build affordable housing projects in Sibu, Sarawak, under the 13th Malaysia Plan, saying that there are no such homes in the constituency.
DAP's Oscar Ling (PH-Sibu) said there have been no affordable housing projects developed by the federal government in Sibu to date.
Oscar Ling.
'The only affordable housing project under the housing and local government is in Sibu Jaya and that can be considered abandoned,' he told the Dewan Rakyat during the debate on the 13MP today.
'My constituents are asking whether this project will continue under the 13MP.
'We cannot allow Sibu to be left behind in the national housing agenda.'
Ling said many in the lower- and middle-income groups in Sibu were waiting for affordable homes
He suggested that Putrajaya consider building affordable homes in Sungai Bidut in Sibu's West Bank area.
He said the West Bank had great potential for development, citing a recent state government project to build a bridge connecting the area with the Sibu city centre.
Sibu Hospital in dire need of upgrades
The three-term MP also said Sibu Hospital was nearly at maximum capacity, pointing out that it serves as the main hospital for referrals in Sarawak's entire central region.
'The hospital is facing space limitations and insufficient facilities. The demand for specialist services is increasing year-on-year,' he said.
Ling called for the 13MP to include a new building for the hospital in line with plans to turn it into a regional hospital like the Miri Hospital, and Sarawak General Hospital (SGH) in Kuching.
He said radiotherapy treatment services were currently only available at SGH, forcing cancer patients from areas like Kapit and Song to incur high travel and accommodation costs to receive treatment.
He also said it was time for Sibu Hospital to have its own oncology department equipped with the necessary facilities as well as human resources and treatment capabilities.
'This can only be achieved if a new Sibu Hospital building is built with specific plans to accommodate such facilities,' he said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Malaysia sets sights on becoming Asean pharmaceutical and healthcare hub
Malaysia sets sights on becoming Asean pharmaceutical and healthcare hub

The Sun

time4 hours ago

  • The Sun

Malaysia sets sights on becoming Asean pharmaceutical and healthcare hub

KUALA LUMPUR: Malaysia is setting its sights on becoming a halal pharmaceutical and healthcare hub for Asean, leveraging partnerships with India's booming pharma sector as industry leaders prepare for the Second Malaysia Pharma and Healthcare Expo (MPHC 2025) in October. The expo, to be held at the World Trade Centre Kuala Lumpur from Oct 7 to 9, is expected to attract over 100 companies, up from 70 last year, alongside policymakers, researchers and investors across Asean, India, Australia and South Korea. Organisers say the event will spotlight innovations in halal-certified drugs, active pharmaceutical ingredients (APIs), biotech, regenerative medicine, telehealth and AI-driven diagnostics. Malaysia-India Business Council general secretary Datuk Surendran Menon said trade between Malaysia and India stood at US$20 billion (RM84.6 billion) in 2024, but pharmaceuticals made up just US$96–$104 million of that figure, a sign of significant untapped potential. 'India is known as the pharma of the world, while Malaysia offers halal regulation expertise and a strategic Asean strong potential in contract manufacturing, technology transfer and joint R&D, especially in halal pharmaceuticals and vaccines,' Surendran told reporters at a media briefing today. He said Malaysia imports over 70% of its pharmaceutical products, and the government's national pharmaceutical policy is pushing for greater domestic production, a move that could entice Indian firms seeking to expand into Asean markets. He also pointed to India's own 200 million-strong Muslim population as an untapped market for halal pharma products manufactured in Malaysia. 'Even if we tap just 50 million of that halal market in India, it's far larger than our domestic market here. Halal-certified medicines made in Malaysia could be exported not just across Asean but also back into India itself,' he said. This strategy, he added, would allow two-way investment flows, Indian companies bringing R&D and cost efficiencies to Malaysia, while Malaysian firms could set up manufacturing or joint ventures in India. Asean-India Economic Council chairman Datuk Ramesh Kodammal said Malaysia stands to benefit from India's US$50 billion pharmaceutical export industry, particularly as Asean and India review their free trade agreement, which has been in place for 11 years. 'If we work closely with India, we will have a lot of benefit,' he said, adding Malaysia has a great advantage of re-exporting with these Indian companies for the Asean market a huge market of 700 million people. Ramesh confirmed 40 Indian companies are slated to participate in MPHC 2025, alongside Asean, Australian and South Korean firms.

Indonesia offers nurses to address staffing shortage
Indonesia offers nurses to address staffing shortage

Free Malaysia Today

time5 hours ago

  • Free Malaysia Today

Indonesia offers nurses to address staffing shortage

Indonesia has already begun state-level collaboration with a hospital in Johor, including starting the process of recruiting nursing candidates. PETALING JAYA : The Indonesian consulate-general in Johor Bahru has proposed allowing Indonesian nurses to work in Malaysia to alleviate the manpower shortage in the healthcare sector. The consul-general of Indonesia in Johor Bahru, Sigit S Widiyanto, said the move would benefit both countries as Malaysia is facing a shortage of healthcare workers — including nurses — while Indonesia has a surplus in the field. In a Bernama report, Sigit expressed confidence that Indonesians would have no difficulty adjusting to living in Malaysia as both countries share a similar language and culture. He also said Indonesian nurses are well qualified to work in Malaysia as they are already employed in other countries like Australia, Japan, Germany, Saudi Arabia, the UAE and Singapore. 'If Indonesian nurses can work in those countries, surely they can work in Malaysia. 'Asean member countries have agreed that nursing is among the professions open for cross-border mobility. Of course, there needs to be skill alignment and compliance with existing regulations, but that shouldn't be a major issue.' Sigit said Indonesia has already begun state-level collaboration with a hospital in Johor, including starting the process of recruiting candidates. He said this required approval from the health ministry, the Malaysia Nursing Board and other relevant parties. Sigit also said the consulate plans to focus on recruiting nurses from the Riau and Riau Islands provinces as a starting point to place healthcare professionals in Malaysian hospitals. He noted that there are health education institutions under Indonesia's health ministry which could serve as key sources for nursing candidates. 'We've already discussed establishing a twinning programme to allow graduates in Indonesia to pursue six months of further study in Malaysia before starting work here,' he said. Earlier, Johor menteri besar Onn Hafiz Ghazi said major hospitals in Johor Bahru are facing a critical shortage of healthcare staff, with some nurses managing 10 to 14 patients per shift. He said the ideal ratio is 1:6. The International Council of Nurses last year called on the government to develop a long-term plan to address a critical shortage of nurses. The council said Malaysia's shortage – projected to reach nearly 60% of the total nursing workforce by 2030 – had been exacerbated by high-income nations hiring experienced nurses from Asia, attracting them with better pay and working conditions. Last June, the health ministry said it was addressing 6,787 vacant nursing posts caused by both existing vacancies and newly created positions following facility upgrades.

Sarawak emerges as leading state for first-in-human cancer drug trials
Sarawak emerges as leading state for first-in-human cancer drug trials

Free Malaysia Today

time8 hours ago

  • Free Malaysia Today

Sarawak emerges as leading state for first-in-human cancer drug trials

Sarawak deputy premier Dr Sim Kui Hian said these achievements have put the state on the global map and demonstrate that local expertise can meet international research standards. KUALA LUMPUR : Sarawak has emerged as the leading state for first-in-human clinical trials in Malaysia, with Sarawak General Hospital (SGH) playing a key role in testing new cancer drugs. Deputy premier Dr Sim Kui Hian said the state had now conducted eight such trials, and that of the 25 new oncology drugs developed and marketed globally, eight had a footprint in Sarawak. 'Before last year, there had never been a first-in-human trial done in Malaysia. People didn't trust us, or we were not up to expectations. 'But since last year, first-in-human clinical trials have been done in Malaysia, five last year alone. Four of them were done at SGH, and there are four more this year,' he said at the 5th Asean International Oncology Integrative Medicine Session here today. First-in-human trials involve testing new drugs on people for the first time and are considered critical in the development of life-saving treatments, particularly for cancer. Sim said these achievements had put Sarawak on the global map and demonstrated that local expertise could meet international research standards. 'This shows that we are no longer just seen as a third-world country. If you don't have first-in-human trials, there will be no new drug discoveries for cancer.' He added that 155 clinical trials had been conducted in the state, making it one of the top contributors among 267 trial sites across Malaysia. He also said such trials were governed by strict international standards. 'You cannot just say, 'I want to be a first-in-human site'. These sites are monitored very strictly, not just by Malaysians, but by the companies as well,' he said. 'Worldwide, there are only about 30 sites that meet these standards, so you must be a top-tier centre to qualify.' Despite these achievements, Sim expressed concern over the state of facilities at SGH's cancer centre. 'In Sarawak, I always say, you go to the cancer department not sick but (then) become sick, because the facilities are not ideal, not up to standard,' he said. He said the federal government had cited financial constraints when asked for funds to upgrade the facilities. 'So the Sarawak government said, let's form a partnership. The Sarawak government will come in with RM1 billion first. If that's not enough, let us know, and when the federal government has money, they can start paying us back. 'Are we supposed to wait until there's money? By then people would have died. We care more about saving lives first,' he added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store